Literature DB >> 1339275

A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer.

M Husmann1, B Hoffmann, D G Stump, F Chytil, M Pfahl.   

Abstract

The expression of the rat cellular retinol binding protein I (rCRBPI) can be upregulated in vivo by retinoic acid (RA). Here we have analyzed the rCRBPI promoter region and compared it to the corresponding mouse sequence. We find that the CRBPI 5' flanking region has been highly conserved between rat and mouse, including a RA response element (RARE) approximately 1 kb upstream of the start of transcription. The RARE is of the direct repeat type with a two nucleotide spacer. Like other direct repeat RAREs, this response element is activated by RAR alpha and beta but not by RAR gamma 1. Furthermore, the rCRBPI-RARE is most effectively activated when both RAR and RXR are present. In addition RAR/RXR heterodimers are required for efficient binding to the rCRBPI-RARE, while RARs or RXR alone do not interact effectively with this response element. The rCRBPI gene is therefore most likely activated in vitro by a RAR/RXR heterodimer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339275     DOI: 10.1016/0006-291x(92)90480-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

Authors:  M R Song; S K Lee; Y W Seo; H S Choi; J W Lee; M O Lee
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

2.  Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs.

Authors:  G Xu; M Redard; G Gabbiani; P Neuville
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

3.  The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal.

Authors:  N La Vista-Picard; P D Hobbs; M Pfahl; M I Dawson; M Pfahl
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

4.  Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells.

Authors:  T Tanaka; B L Dancheck; L C Trifiletti; R E Birnkrant; B J Taylor; S H Garfield; U Thorgeirsson; L M De Luca
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.

Authors:  I Zamir; H P Harding; G B Atkins; A Hörlein; C K Glass; M G Rosenfeld; M A Lazar
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter.

Authors:  M O Lee; P D Hobbs; X K Zhang; M I Dawson; M Pfahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Anti-tumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and retinoic acids.

Authors:  Shaoteng Han; Takuya Fukazawa; Tomoki Yamatsuji; Junji Matsuoka; Hiroyuki Miyachi; Yutaka Maeda; Mary Durbin; Yoshio Naomoto
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

9.  Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism.

Authors:  Kingsley Osuala; Candice N Baker; Ha-Long Nguyen; Celines Martinez; David Weinshenker; Steven N Ebert
Journal:  Physiol Genomics       Date:  2012-08-21       Impact factor: 3.107

Review 10.  Retinoic acid signaling in mammalian eye development.

Authors:  Ales Cvekl; Wei-Lin Wang
Journal:  Exp Eye Res       Date:  2009-05-07       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.